ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,364Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 337

$945K Total Retail Price of All Prescriptions

Rank: 13 out of 337

334 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 334 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

10% of this provider’s 334 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

0% of this provider’s 18,091 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

58 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
WARFARIN SODIUM 1,965 1,865 1 11
FUROSEMIDE 1,075 1,031 2 8
TRAZODONE HCL 765 710 3 16
SERTRALINE HCL 629 589 4 18
SIMVASTATIN 615 566 5 1
NAMENDA 571 571 6 35
METOPROLOL TARTRATE 567 567 7 6
LEVOTHYROXINE SODIUM 534 496 8 5
LISINOPRIL 459 450 9 2
DONEPEZIL HCL 458 452 10 22
MIRTAZAPINE 443 419 11 27
AMLODIPINE BESYLATE 395 382 12 3
OMEPRAZOLE 361 343 13 4
ESCITALOPRAM OXALATE 265 255 14 66
EXELON 230 219 15 85
LANTUS 206 197 16 49
ATORVASTATIN CALCIUM 204 196 17 7
PANTOPRAZOLE SODIUM 203 203 18 36
QUETIAPINE FUMARATE 176 148 19 61
DIGOXIN 167 167 20 58
IPRATROPIUM-ALBUTEROL 160 156 21 96
GABAPENTIN 156 127 22 20
POTASSIUM CHLORIDE 142 140 23 62
CITALOPRAM HBR 142 140 23 17
HYDROCODONE-ACETAMINOPHEN 136 119 S3 25 13
OXYCODONE HCL 135 102 S2 26 63
GLIPIZIDE 128 128 27 45
CLOPIDOGREL 128 110 27 42
FENTANYL 126 126 S2 29 138
POLYETHYLENE GLYCOL 3350 126 125 29 47
ADVAIR DISKUS 125 125 31 44
NOVOLOG 124 121 32 106
DILTIAZEM 24HR CD 122 122 33 104
BISOPROLOL FUMARATE 120 120 34 67
ATENOLOL 115 115 35 10
CARBIDOPA-LEVODOPA 111 100 36 92
TRAMADOL HCL 110 102 37 32
CARVEDILOL 109 89 38 73
ALBUTEROL SULFATE 108 90 39 131
OLANZAPINE 107 83 40 108
LOSARTAN POTASSIUM 106 106 41 15
DIOVAN 106 106 41 26
CYMBALTA 104 79 43 59
VENLAFAXINE HCL ER 103 103 44 86
FAMOTIDINE 103 103 44 115
PREDNISONE 101 87 46 40
HYDROCHLOROTHIAZIDE 100 100 47 9
LEVOFLOXACIN 99 97 48 93
KLOR-CON M20 99 90 48 65
TAMSULOSIN HCL 98 91 50 25
RISPERIDONE 95 95 51 72
METOPROLOL SUCCINATE 94 80 52 21
ALENDRONATE SODIUM 81 81 53 19
HYDRALAZINE HCL 81 81 53 122
SPIRIVA 79 79 55 43
PROCRIT 79 26 55 214
SEROQUEL 74 57 57 107
PLAVIX 73 63 58 74
PRAVASTATIN SODIUM 72 72 59 14
BACLOFEN 70 53 60 133
CIPROFLOXACIN HCL 67 67 61 71
OXYCONTIN 67 53 S2 61 87
ISOSORBIDE MONONITRATE ER 65 65 63 70
METFORMIN HCL 65 53 63 12
LATANOPROST 65 54 63 120
PAROXETINE HCL 63 63 66 46
METOLAZONE 62 62 67 247
CLOZAPINE 62 62 67 94
VENLAFAXINE HCL 60 60 69 168
LEXAPRO 59 54 70 169
ABILIFY 58 23 71 145
KLOR-CON M10 58 57 71 162
TAMIFLU 56 56 73 147
RAMIPRIL 55 53 74 80
HYDROXYZINE HCL 53 39 R 75 179
CHLORHEXIDINE GLUCONATE 53 53 75 183
OXYCODONE-ACETAMINOPHEN 51 50 S2 77 84
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 16, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.